Searchable abstracts of presentations at key conferences in endocrinology

ea0091p35 | Poster Presentations | SFEEU2023

Severe hyperprolactinaemia associated with domperidone with normal MRI pituitary

Thackray Kerrie , Kaplan Felicity

Section 1: Case History: A 28 year old female initially presented to Endocrinology in 2020 with hirsutism and irregular menstruation but reassuring biochemistry. In 2022, she was referred to Gastroenterology with weight loss, vomiting and dyspepsia and found to have severe hyperprolactinaemia. Past medical history included anxiety/depression. Current medication was esomeprazole 40mg OD and mebeverine 135mg TDS. Cyclizine 50mg TDS had previously been prescribed, followed by dom...

ea0091wc9 | Workshop C: Disorders of the thyroid gland | SFEEU2023

Management of alemtuzumab-associated Graves’ disease in pregnancy

Thackray Kerrie , Narayanaswamy Shakunthala , Kaplan Felicity

A 31 year old female patient initially presented with a two month history of unintentional weight loss. Past medical history included multiple sclerosis, for which she had last received alemtuzumab immunotherapy five months previously. Thyroid function tests (TFTs) demonstrated hyperthyroidism, with Thyroid Stimulating Immunoglobulins (TSI) 5.71 iu/l(NR: <0.56). She was diagnosed with GravesÂ’ disease, possibly induced by alemtuzumab, and commenced on carbimazole. She ...